Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Access and Attitudes to HPV Vaccination amongst Hard-To-Reach Populations in Kenya.

Watson-Jones D, Mugo N, Lees S, Mathai M, Vusha S, Ndirangu G, Ross DA.

PLoS One. 2015 Jun 26;10(6):e0123701. doi: 10.1371/journal.pone.0123701. eCollection 2015.

2.

A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania.

Remes P, Selestine V, Changalucha J, Ross DA, Wight D, de Sanjosé S, Kapiga S, Hayes RJ, Watson-Jones D.

Vaccine. 2012 Aug 3;30(36):5363-7. doi: 10.1016/j.vaccine.2012.06.025. Epub 2012 Jun 22.

3.

Implementation of an HPV vaccination program in Eldoret, Kenya: results from a qualitative assessment by key stakeholders.

Vermandere H, Naanyu V, Degomme O, Michielsen K.

BMC Public Health. 2015 Sep 10;15:875. doi: 10.1186/s12889-015-2219-y.

4.

Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya.

Masika MM, Ogembo JG, Chabeda SV, Wamai RG, Mugo N.

PLoS One. 2015 Aug 12;10(8):e0135563. doi: 10.1371/journal.pone.0135563. eCollection 2015.

5.

Preparing for human papillomavirus vaccine introduction in Kenya: implications from focus-group and interview discussions with caregivers and opinion leaders in Western Kenya.

Friedman AL, Oruko KO, Habel MA, Ford J, Kinsey J, Odhiambo F, Phillips-Howard PA, Wang SA, Collins T, Laserson KF, Dunne EF.

BMC Public Health. 2014 Aug 16;14:855. doi: 10.1186/1471-2458-14-855.

6.

Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya.

Vermandere H, Naanyu V, Mabeya H, Vanden Broeck D, Michielsen K, Degomme O.

PLoS One. 2014 Oct 9;9(10):e109353. doi: 10.1371/journal.pone.0109353. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0117761.

7.

Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.

Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N, Plant A, Guerry S.

Vaccine. 2012 Jun 22;30(30):4511-6. doi: 10.1016/j.vaccine.2012.04.062. Epub 2012 May 3.

PMID:
22561142
8.

Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents.

La Vincente SF, Mielnik D, Jenkins K, Bingwor F, Volavola L, Marshall H, Druavesi P, Russell FM, Lokuge K, Mulholland EK.

BMC Public Health. 2015 Dec 18;15:1257. doi: 10.1186/s12889-015-2579-3.

9.

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries.

Kabakama S, Gallagher KE, Howard N, Mounier-Jack S, Burchett HE, Griffiths UK, Feletto M, LaMontagne DS, Watson-Jones D.

BMC Public Health. 2016 Aug 19;16(1):834. doi: 10.1186/s12889-016-3517-8.

10.

Perceptions of HPV and cervical cancer among Haitian immigrant women: implications for vaccine acceptability.

Kobetz E, Menard J, Hazan G, Koru-Sengul T, Joseph T, Nissan J, Barton B, Blanco J, Kornfeld J.

Educ Health (Abingdon). 2011 Dec;24(3):479. Epub 2011 Dec 7.

PMID:
22267344
11.
12.

Perceptions of HPV and attitudes towards HPV vaccination amongst men who have sex with men: A qualitative analysis.

Nadarzynski T, Smith H, Richardson D, Pollard A, Llewellyn C.

Br J Health Psychol. 2017 May;22(2):345-361. doi: 10.1111/bjhp.12233. Epub 2017 Feb 13.

PMID:
28191723
13.

'A false sense of security'? Understanding the role of the HPV vaccine on future cervical screening behaviour: a qualitative study of UK parents and girls of vaccination age.

Henderson L, Clements A, Damery S, Wilkinson C, Austoker J, Wilson S; HPV Core Messages Writing Group.

J Med Screen. 2011;18(1):41-5. doi: 10.1258/jms.2011.010148.

14.

Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.

Msyamboza KP, Mwagomba BM, Valle M, Chiumia H, Phiri T.

BMC Public Health. 2017 Jun 26;17(1):599. doi: 10.1186/s12889-017-4526-y.

15.

Barriers and facilitators to HPV vaccination: perspectives from Malawian women.

Ports KA, Reddy DM, Rameshbabu A.

Women Health. 2013;53(6):630-45. doi: 10.1080/03630242.2013.809046. Erratum in: Women Health. 2015;55(1):118.

16.

Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.

Jaspers L, Budiningsih S, Wolterbeek R, Henderson FC, Peters AA.

Vaccine. 2011 Oct 13;29(44):7785-93. doi: 10.1016/j.vaccine.2011.07.107. Epub 2011 Aug 5.

PMID:
21821079
17.

Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.

Wong LP.

J Low Genit Tract Dis. 2009 Apr;13(2):85-93. doi: 10.1097/LGT.0b013e3181865f44.

PMID:
19387128
18.

Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis.

Ferrer HB, Trotter C, Hickman M, Audrey S.

BMC Public Health. 2014 Jul 9;14:700. doi: 10.1186/1471-2458-14-700. Review.

19.

Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.

Marek E, Dergez T, Rebek-Nagy G, Kricskovics A, Kovacs K, Bozsa S, Kiss I, Ember I, Gocze P.

Vaccine. 2011 Nov 3;29(47):8591-8. doi: 10.1016/j.vaccine.2011.09.018. Epub 2011 Sep 21.

PMID:
21939711
20.

Human papillomavirus vaccine introduction in Vietnam: formative research findings.

Nghi NQ, Lamontagne DS, Bingham A, Rafiq M, Mai le TP, Lien NT, Khanh NC, Hong DT, Huyen DT, Tho NT, Hien NT.

Sex Health. 2010 Sep;7(3):262-70. doi: 10.1071/SH09123.

PMID:
20719213

Supplemental Content

Support Center